<DOC>
	<DOCNO>NCT00269061</DOCNO>
	<brief_summary>This study use Magnetic Resonance Imaging ( MRI ) techniques evaluate change fluid volume low legs diabetic patient add either pioglitazone placebo current diabetic regimen .</brief_summary>
	<brief_title>Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea , Metformin And Insulin , Or Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Inclusion criterion : Must diagnose Type 2 diabetes least three month prior screen . Must take either metformin sulfonylurea , metformin insulin , insulin , dose medication must stable least three month . Must Body Mass Index ( BMI ) 24 35 . If female , subject must postmenopausal . HbA1c level must 7 % 10 % . Subjects must eligible MRI scan ( ie , metal implant , pacemaker , etc ) . Exclusion criterion : Suffer claustrophobia . Use tobacco , nicotine , illegal drug abuse . Use caffeine within two day prior study visit . HIV , hepatitis , edema , untreated blood pressure problem , heart , lung , nervous system kidney disease , history blood clot legs , diabetic neuropathy , untreated thyroid disease . Use drug medication affect level fluid body , diuretic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>pioglitazone</keyword>
	<keyword>diabetes</keyword>
	<keyword>fluid</keyword>
</DOC>